| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Alpha‐HIT assay: A new assay for heparin‐induced thrombocytopenia antibody detection using FcγRIIa‐coated beads and Alpha technology
|
Maruyama, Keiko
|
|
|
6 |
7 |
p.
|
article
|
| 2 |
Anti‐platelet factor 4/heparin antibodies in patients with Hantaan virus infection
|
Wang, Meng
|
|
|
6 |
7 |
p.
|
article
|
| 3 |
Antithrombotic treatment switching in elderly patients with atrial fibrillation and the risk of thromboembolism, bleeding, and cardiac death
|
Ehrlinder, Hanne
|
|
|
6 |
7 |
p.
|
article
|
| 4 |
Blocking domain 6 of high molecular weight kininogen to understand intrinsic clotting mechanisms
|
Singh, Pradeep K.
|
|
|
6 |
7 |
p.
|
article
|
| 5 |
Building a better NET: Neutrophil extracellular trap targeted therapeutics in the treatment of infectious and inflammatory disorders
|
Ngo, Anh T.P.
|
|
|
6 |
7 |
p.
|
article
|
| 6 |
Burden of congenital hemophilia A requiring treatment in Japan: The HIKOBOSHI study
|
Nagao, Azusa
|
|
|
6 |
7 |
p.
|
article
|
| 7 |
Case‐fatality rate of major bleeding events in patients on dual antiplatelet therapy after percutaneous coronary intervention: A systematic review and meta‐analysis
|
Tritschler, Tobias
|
|
|
6 |
7 |
p.
|
article
|
| 8 |
Comparison of analytical performances between clot waveform analysis and FibWave in edoxaban‐treated patients and healthy controls
|
Evrard, Jonathan
|
|
|
6 |
7 |
p.
|
article
|
| 9 |
Corrigendum
|
|
|
|
6 |
7 |
p.
|
article
|
| 10 |
Cryo‐EM structures of coagulation factors
|
Di Cera, Enrico
|
|
|
6 |
7 |
p.
|
article
|
| 11 |
Current practices in pediatric hospital‐acquired thromboembolism: Survey of the Children's Hospital Acquired Thrombosis (CHAT) Consortium
|
Abrams, Christina M.
|
|
|
6 |
7 |
p.
|
article
|
| 12 |
Early indicators of neonatal‐onset hereditary thrombotic thrombocytopenia purpura
|
Liu, Jing
|
|
|
6 |
7 |
p.
|
article
|
| 13 |
Effect of wavelength and filter set choices on fluorogenic thrombin generation assay: Considerations for interlaboratory differences
|
Jackson, Joseph W.
|
|
|
6 |
7 |
p.
|
article
|
| 14 |
Epitope of antiphospholipid antibodies retrieved from peptide microarray based on R39‐R43 of β2‐glycoprotein I
|
Moghbel, Marc
|
|
|
6 |
7 |
p.
|
article
|
| 15 |
Genetic variation of the blood coagulation regulator tissue factor pathway inhibitor and venous thromboembolism among middle‐aged and older adults: A population‐based cohort study
|
Manderstedt, Eric
|
|
|
6 |
7 |
p.
|
article
|
| 16 |
Hand grip strength and risk of incident venous thromboembolism: The Tromsø study
|
Leknessund, Oda G.R.
|
|
|
6 |
7 |
p.
|
article
|
| 17 |
Hereditary thrombotic thrombocytopenic purpura and COVID‐19: Impacts of vaccination and infection inrare disease
|
Tarasco, Erika
|
|
|
6 |
7 |
p.
|
article
|
| 18 |
Issue Information
|
|
|
|
6 |
7 |
p.
|
article
|
| 19 |
Low‐dose immune tolerance induction in children with severe hemophilia A with high‐titer inhibitors: Type of factor 8 mutation and outcomes
|
Sun, Jie
|
|
|
6 |
7 |
p.
|
article
|
| 20 |
Lower levels of vWF are associated with lower risk of cardiovascular disease
|
van Paridon, Pauline C.S.
|
|
|
6 |
7 |
p.
|
article
|
| 21 |
Modulation of thromboinflammation in hospitalized COVID‐19 patients with aprotinin, low molecular weight heparin, and anakinra: The DAWn‐Antico study
|
Engelen, Matthias M.
|
|
|
6 |
7 |
p.
|
article
|
| 22 |
Pooled Analysis of Rivaroxaban therapy for acute venous thromboembolism in FIRST registry, SWIVTER and DRESDEN NOAC registry
|
Müller, Stephanie
|
|
|
6 |
7 |
p.
|
article
|
| 23 |
Properdin (factor P) as a new target cleaved by factor XIa: Intrinsic coagulation at the crossroads with inflammation
|
Luo, Qi
|
|
|
6 |
7 |
p.
|
article
|
| 24 |
Risk of venous thromboembolism in pediatric hospitalized patients undergoing noncardiac surgery: A report from the Children's Hospital‐Acquired Thrombosis consortium
|
Stephens, Elizabeth T.
|
|
|
6 |
7 |
p.
|
article
|
| 25 |
Ristocetin dependent cofactor activity in von Willebrand disease diagnosis: Limitations of relying on a single measure
|
Christopherson, Pamela A.
|
|
|
6 |
7 |
p.
|
article
|
| 26 |
Selective human factor VIII activity measurement after analytical in‐line purification
|
Engelmaier, Andrea
|
|
|
6 |
7 |
p.
|
article
|
| 27 |
Stability of specimens for use in the Centers for Disease Control and Prevention assays for factor VIII and IX inhibitors
|
Payne, Amanda B.
|
|
|
6 |
7 |
p.
|
article
|
| 28 |
Standardizing definitions for bleeding events in studies including pregnant women: A call to action
|
Saeed, Khalid
|
|
|
6 |
7 |
p.
|
article
|
| 29 |
Unmet definitions in thromboprophylaxis for hospitalized medical patients: An appraisal for the need of recommendation
|
Ávila Ferreira, Bruno
|
|
|
6 |
7 |
p.
|
article
|
| 30 |
Untreated bleeds: Unveiling the subtleties and challenges of bleeding event counts and patient experience in clinical trials for bleeding disorders
|
Warren, Beth B.
|
|
|
6 |
7 |
p.
|
article
|
| 31 |
Venous thromboembolism in critically ill patients with pneumonia in the pre‐COVID‐19 era: Data from a large public database
|
Pisani, Miguel
|
|
|
6 |
7 |
p.
|
article
|
Journal description